Marco Roffi

116.1k total citations · 7 hit papers
271 papers, 16.6k citations indexed

About

Marco Roffi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marco Roffi has authored 271 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Cardiology and Cardiovascular Medicine, 128 papers in Surgery and 74 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Roffi's work include Acute Myocardial Infarction Research (101 papers), Coronary Interventions and Diagnostics (88 papers) and Cardiac Valve Diseases and Treatments (52 papers). Marco Roffi is often cited by papers focused on Acute Myocardial Infarction Research (101 papers), Coronary Interventions and Diagnostics (88 papers) and Cardiac Valve Diseases and Treatments (52 papers). Marco Roffi collaborates with scholars based in Switzerland, United States and United Kingdom. Marco Roffi's co-authors include Stephan Windecker, Debabrata Mukherjee, Marco Valgimigli, Derek P. Chew, Keld Kjeldsen, Bariş Gencer, Carlo Patrono, Julinda Mehilli, Christian Mueller and Robert F. Storey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Marco Roffi

255 papers receiving 16.1k citations

Hit Papers

2015 ESC Guidelines for the management of acute coronary ... 2014 2026 2018 2022 2015 2014 2016 2016 2018 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    2015 5.1k citations Marco Roffi, Carlo Patrono et al. European Heart Journal profile →
  2. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
    2014 2.9k citations Raimund Erbel, Victor Aboyans et al. European Heart Journal profile →
  3. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
    2016 564 citations Marco Roffi, Keld Kjeldsen et al. European Heart Journal profile →
  4. Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC)
    2016 413 citations Marco Roffi, Carlo Patrono et al. Giornale italiano di cardiologia profile →
  5. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    2018 371 citations Héctor Bueno, Adnan Kastrati et al. Kardiologia Polska profile →
  6. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    2017 332 citations Héctor Bueno, Adnan Kastrati et al. profile →
  7. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    2015 329 citations Marco Roffi, Carlo Patrono et al. Kardiologia Polska profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Roffi Switzerland 45 12.1k 6.5k 4.7k 3.6k 1.6k 271 16.6k
Ryan J. Lennon United States 62 8.8k 0.7× 6.0k 0.9× 2.1k 0.4× 3.6k 1.0× 1.2k 0.7× 298 13.7k
Guy S. Reeder United States 63 11.4k 0.9× 5.8k 0.9× 3.4k 0.7× 4.8k 1.3× 2.3k 1.5× 293 15.0k
Sabino Iliceto Italy 67 12.0k 1.0× 3.7k 0.6× 2.4k 0.5× 3.8k 1.1× 2.1k 1.3× 521 16.2k
Paolo Marino Italy 44 17.5k 1.4× 4.1k 0.6× 2.3k 0.5× 5.9k 1.6× 1.9k 1.2× 272 20.7k
Emmanouil S. Brilakis United States 57 8.0k 0.7× 10.3k 1.6× 3.3k 0.7× 5.3k 1.5× 915 0.6× 698 14.2k
Peter B. Berger United States 76 16.2k 1.3× 10.5k 1.6× 2.5k 0.5× 3.6k 1.0× 1.5k 0.9× 360 22.6k
Giuseppe Sangiorgi Italy 57 6.4k 0.5× 6.7k 1.0× 4.1k 0.9× 3.3k 0.9× 902 0.6× 256 11.5k
Julinda Mehilli Germany 80 21.5k 1.8× 15.1k 2.3× 4.3k 0.9× 7.2k 2.0× 2.2k 1.4× 374 27.3k
Howard C. Herrmann United States 60 15.8k 1.3× 5.5k 0.8× 4.4k 0.9× 2.5k 0.7× 6.5k 4.0× 278 18.5k
Franz‐Josef Neumann Germany 62 12.8k 1.1× 7.1k 1.1× 2.5k 0.5× 2.7k 0.7× 2.6k 1.6× 285 16.5k

Countries citing papers authored by Marco Roffi

Since Specialization
Citations

This map shows the geographic impact of Marco Roffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Roffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Roffi more than expected).

Fields of papers citing papers by Marco Roffi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Roffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Roffi. The network helps show where Marco Roffi may publish in the future.

Co-authorship network of co-authors of Marco Roffi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Roffi. A scholar is included among the top collaborators of Marco Roffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Roffi. Marco Roffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruno, Francesco, Florian A. Wenzl, Ovidio De Filippo, et al.. (2024). Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study. European Heart Journal - Cardiovascular Pharmacotherapy. 10(5). 391–402. 1 indexed citations
2.
3.
Wagener, Max, Oliver Reuthebuch, Dik Heg, et al.. (2023). Clinical Outcomes in High‐Gradient, Classical Low‐Flow, Low‐Gradient, and Paradoxical Low‐Flow, Low‐Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation: A Report From the SwissTAVI Registry. Journal of the American Heart Association. 12(12). e029489–e029489. 21 indexed citations
4.
Wenzl, Florian A., Francesco Bruno, Simon Kraler, et al.. (2023). Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes. European Heart Journal. 44(38). 3859–3871. 27 indexed citations
5.
Mamas, Mamas A., Marco Roffi, Ole Fröbert, et al.. (2023). Predicting target lesion failure following percutaneous coronary intervention through machine learning risk assessment models. European Heart Journal - Digital Health. 4(6). 433–443. 4 indexed citations
6.
Schuit, Ewoud, Rieke van der Graaf, Rolf H. H. Groenwold, et al.. (2022). Applicability of European Society of Cardiology guidelines according to gross national income. European Heart Journal. 44(7). 598–607. 16 indexed citations
7.
8.
9.
Mohamed, Mohamed O., Jawed Polad, David Hildick‐Smith, et al.. (2020). Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry. EuroIntervention. 16(7). 603–612. 44 indexed citations
10.
Roffi, Marco, François Mach, Xavier M. Mueller, et al.. (2018). Coronary stent thrombosis in acute coronary syndromes. Cardiovascular Medicine. 1 indexed citations
11.
Räber, Lorenz, Konstantinos C. Koskinas, Kyohei Yamaji, et al.. (2018). Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4). JACC. Cardiovascular imaging. 12(8). 1518–1528. 78 indexed citations
12.
Valgimigli, Marco, Héctor Bueno, Robert A. Byrne, et al.. (2017). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Kardiologia Polska. 75(12). 1217–1299. 94 indexed citations
13.
Roffi, Marco, Carlo Patrono, Jean‐Philippe Collet, et al.. (2016). Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC). Giornale italiano di cardiologia. 17(10). 413 indexed citations breakdown →
14.
Roffi, Marco, Carlo Patrono, Jean‐Philippe Collet, et al.. (2015). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 37(3). 267–315. 5104 indexed citations breakdown →
15.
Erbel, Raimund, Victor Aboyans, Cathérine Boileau, et al.. (2014). 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. European Heart Journal. 35(41). 2873–2926. 2871 indexed citations breakdown →
16.
Roffi, Marco, et al.. (2014). Platypnoea-orthodeoxia syndrome: more than just a PFO. Cardiovascular Medicine. 17(708). 228–231.
17.
Fröhlich, Georg, Alexandra J. Lansky, John G. Webb, et al.. (2014). Local versus general anesthesia for transcatheter aortic valve implantation (TAVR) – systematic review and meta-analysis. BMC Medicine. 12(1). 41–41. 119 indexed citations
18.
Husmann, Marc, et al.. (2012). Influence of plaque volume on hemodynamic response and stress hormone release in patients undergoing carotid artery stenting.. PubMed. 31(1). 10–5. 2 indexed citations
19.
Widimský, Petr, J. Wouter Jukema, Bernhard Meier, et al.. (2012). Evolving strategies in the management of acute coronary syndromes with oral antiplatelet agents. Cor et Vasa. 54(1-2). e32–e38. 4 indexed citations
20.
Park, Chanil, et al.. (2011). High-risk pulmonary embolism with impending paradoxical embolism successfully treated with percutaneous catheter-based thrombectomy. Cardiovascular Medicine. 14(4). 127–130. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan J. Lennon Breakdown of academic impact, for papers by Guy S. Reeder Breakdown of academic impact, for papers by Sabino Iliceto Breakdown of academic impact, for papers by Paolo Marino Breakdown of academic impact, for papers by Emmanouil S. Brilakis Breakdown of academic impact, for papers by Peter B. Berger Breakdown of academic impact, for papers by Giuseppe Sangiorgi Breakdown of academic impact, for papers by Julinda Mehilli Breakdown of academic impact, for papers by Howard C. Herrmann Breakdown of academic impact, for papers by Franz‐Josef Neumann
Rankless by CCL
2026